Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Formulations of anti-LAG3 antibodies and co-formulations of anti-LAG3 antibodies and anti-PD-1 antibodies

Formulations of anti-LAG3 antibodies and co-formulations of anti-LAG3 antibodies and anti-PD-1 antibodies

US Patent 11845798 · Granted Dec 19, 2023

Estimated economic value: $689,811,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Electrospun film, method for manufacturing the same and use of such electrospun 2025
Preparation method of a unidirectional moisturizing nanofiber facial mask substr2025
Co-formulations of anti-LAG3 antibodies and anti-PD-1 antibodies2025
Co-formulations of anti-LAG3 antibodies and anti-PD-1 antibodies2025
Pharmaceutical formulation comprising incretin-insulin conjugates2023
Pharmaceutical formulation comprising incretin-insulin conjugates2023
Network standard switching method and apparatus, and device2021
Chewable dosage forms containing sitagliptin and metformin2021
System and method for handling network fault identified according to amounts of 2021
Signal processing method and user equipment2020
Method for simulating magnetic flux leakage based on loop current2020
Liquid formulations for an anti-TNF α antibody2017